According to the 2016 updated staging of breast cancer by the American Joint Committee on Cancer (AJCC), TNM stage, tumor grade and expression of ER/PR and Her2/neu are the three main parameters utilized for prognostic staging of breast cancer, which is then used to shape the treatment plan [29]. This evidence concerns the gene ERBB2 and neoplasm.